How to cite this article: Ozden, O. et al. Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer. The gene discussed is PARP1; the disease is colonic neoplasm.